AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Flexar 20mg Tablet DT

Prescription Icon
Prescription Required

Marketer

A. Menarini India Pvt Ltd

Salt Composition

Piroxicam (20mg)

Overview Flexar 20mg Tablet DT

Arthroflex 20mg Delayed-Release Tablets offer relief from moderate to severe pain associated with conditions like osteoarthritis and rheumatoid arthritis. This medication targets joint and muscle pain and inflammation. Always take Arthroflex 20mg with food to minimize stomach upset. Dosage and treatment length are determined by your condition and response to treatment; continue taking it as directed, even with symptom improvement, until your physician advises otherwise. Common side effects may include nausea, mild vomiting, headache, stomach discomfort, and dizziness. Persistent or worsening side effects warrant immediate medical attention; your doctor can offer management strategies. Prior to use, inform your doctor of any pre-existing conditions such as ulcers, heart problems, hypertension, or liver/kidney disease. Full disclosure of all other medications is crucial, as interactions are possible. Pregnant or breastfeeding individuals must consult their doctor before using Arthroflex 20mg.

Uses of Flexar 20mg Tablet DT

Analgesia

Major Benefits of Flexar 20mg Tablet DT:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the 20mg Flexar DT tablet in water before consumption. It should be taken with food.

Common Side effects of Flexar 20mg Tablet DT:

  • Vomiting
  • Stomach pain
  • Nausea
  • Headache
  • Dizziness

How to use Flexar 20mg Tablet DT:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Always dissolve the Flexar 20mg Tablet DT in water before consumption. Administer this medication with a meal.

How Flexar 20mg Tablet DT works:

Duraflex 20mg Extended-Release Tablets are a non-steroidal anti-inflammatory medication, inhibiting the production of inflammatory mediators that cause pain and edema.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Flexar 20mg DT tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Flexar 20mg DT tablets during pregnancy poses a confirmed risk to the fetus. While generally contraindicated, a physician might exceptionally prescribe it in critical circumstances where the potential advantages outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Flexar 20mg Tablet DT while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving may be impaired by Flexar 20mg Tablet DT, which can cause drowsiness, dizziness, and visual disturbances. Refrain from operating a vehicle if such effects are experienced.

KidneyKidneyCAUTION

The use of Flexar 20mg Tablet DT requires careful consideration in individuals with advanced kidney impairment. Dosage modification of Flexar 20mg Tablet DT might be necessary. Physician consultation is recommended.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise prudence when using Flexar 20mg Tablet DT. Dosage modification for Flexar 20mg Tablet DT might be necessary. Physician consultation is advised.

What if you forget to take Flexar 20mg Tablet DT :

Should you forget a Flexar 20mg Tablet DT dose, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Flexar 20mg Tablet DT

LabelValue
Type of Compound Compounds derived from enolic acids
Potential for Dependence None.
Treatment Category Medications for Pain Relief

FAQs on Flexar 20mg Tablet DT

Flexar 20mg Tablet DT and diclofenac are analgesics. Piroxicam, a component of Flexar, is a non-selective COX inhibitor, while diclofenac exhibits greater COX-2 selectivity. This enhanced selectivity in diclofenac is believed to reduce the incidence of adverse effects relative to Flexar 20mg Tablet DT.
Flexar 20mg Tablet DT and naproxen are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain. Clinical trials indicate comparable efficacy between the two. Nevertheless, naproxen exhibits a lower incidence of gastrointestinal adverse effects than Flexar 20mg Tablet DT.
Flexar 20mg Tablet DT and meloxicam are analgesics, both non-selectively inhibiting cyclooxygenase, the enzyme mediating inflammation and pain perception. Clinical trials indicate comparable efficacy between the two. Nevertheless, meloxicam demonstrates a lower incidence of acute gastrointestinal adverse events relative to Flexar 20mg Tablet DT.
Flexar 20mg Tablet DT and ketoprofen are both analgesic medications, both non-selectively inhibiting cyclooxygenase (COX), the enzyme mediating inflammation and pain. Clinical trials indicate superior efficacy of topical ketoprofen gel relative to Flexar 20mg Tablet DT. Furthermore, ketoprofen gel demonstrated excellent patient tolerability.
Flexar 20mg Delayed-Release Tablets target cyclooxygenase (COX), an enzyme mediating inflammation and pain. In contrast, Tramadol functions as an opioid analgesic. Tramadol carries a risk of dependence.
Flexar 20mg Tablet DT and nimesulide are analgesics. Flexar 20mg Tablet DT broadly inhibits COX enzymes, crucial in inflammation and pain signaling, while nimesulide targets COX-2 specifically. This targeted action in nimesulide is believed to reduce adverse reactions compared to piroxicam. Its use is contraindicated in children under 12.
Chikungunya typically doesn't cause a decrease in platelet count. However, analgesics such as piroxicam increase the risk of bleeding. Therefore, avoid taking Flexar 20mg Tablet DT or other pain relievers for fever accompanied by joint pain. Always consult a physician before commencing Flexar 20mg Tablet DT.
Flexar 20mg DT tablets and aspirin are distinct medications, despite both being categorized as COX (cyclooxygenase) inhibitors. Both drugs possess anti-inflammatory and analgesic properties.
Concurrent use of Flexar 20mg tablets and dexamethasone is contraindicated due to the synergistic enhancement of their respective toxicities, resulting in a heightened risk of gastrointestinal ulceration.
Concurrent use of methocarbamol and Flexar 20mg DT tablets is considered safe, lacking documented significant adverse interactions. However, physician consultation is advised prior to initiating either treatment.
Confirmation: Concurrent use of paracetamol and Flexar 20mg DT tablets is considered safe, with no documented significant adverse interactions. However, physician consultation is recommended prior to initiating either treatment.
Indeed. Flexar 20mg Delayed-Release Tablets are classified as a non-steroidal anti-inflammatory drug.
The drug Flexar 20mg Tablet DT, a sulfur-based medication, may induce significant adverse reactions in susceptible patients. These can include severe dermatological responses such as Stevens-Johnson syndrome. Always disclose any allergies to your physician.
Flexar 20mg Tablet DT does not reduce blood clotting; it's an analgesic. Patients with bleeding disorders should refrain from using it.
Flexar 20mg Tablet DT does not alleviate muscle tension. Instead, it functions as an analgesic, targeting the COX enzyme (cyclooxygenase), a key player in inflammation and pain generation.
Flexar 20mg Tablet DT is a non-narcotic analgesic. Its mechanism of action involves inhibiting COX enzymes, thereby reducing pain and inflammation.
Flexar 20mg Tablet DT does not treat high blood pressure. Concurrent use with antihypertensive drugs reduces their efficacy. Disclose any antihypertensive medication use to your physician prior to commencing Flexar 20mg Tablet DT.
Concurrent use of Flexar 20mg Tablet DT and Losartan is contraindicated. Combining these medications reduces the efficacy of Losartan's antihypertensive effect, potentially compromising blood pressure control. Prior to commencing Flexar 20mg Tablet DT therapy, patients should disclose all current antihypertensive medication use to their physician.
Concurrent use of Flexar 20mg Tablet DT and lisinopril is contraindicated. Piroxicam, a component of Flexar, reduces the efficacy of lisinopril, potentially compromising blood pressure control. Disclose any antihypertensive medication use to your physician prior to commencing Flexar 20mg Tablet DT treatment.
Confirmed. Concurrent administration of Flexar 20mg Delayed-Release Tablets and calcium channel blockers is acceptable. Studies indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) may diminish the efficacy of most antihypertensive medications, with calcium channel blockers being an exception (White, 2007).
Tizanidine is compatible with Flexar 20mg DT tablets. The analgesic piroxicam and the skeletal muscle relaxant tizanidine are often used together to treat conditions such as back pain.
Affirmative. Concomitant administration of Flexar 20mg Tablet DT and beta-cyclodextrin is permissible. Studies indicate this combination accelerates piroxicam's therapeutic effect and mitigates gastrointestinal adverse reactions.
Affirmative. Substitutes for Flexar 20mg DT tablets exist. Analgesic selection depends on the specific ailment. Physician consultation is recommended prior to commencing piroxicam therapy or switching medications.
Piroxicam should not be used in patients with hypersensitivity, bleeding disorders, duodenal, gastric, or peptic ulcers, mouth sores, systemic lupus erythematosus, ulcerative colitis, upper gastrointestinal problems, late-stage pregnancy, heart conditions, liver dysfunction, or kidney dysfunction.
Flexar 20mg Tablet DT does not alleviate allergic reactions; it is an analgesic.
Piroxicam 20mg extended-release tablets provide prolonged pain relief. While a single daily dose often suffices, individual responses vary, with analgesic efficacy generally improving over several weeks of consistent use.
Flexar 20mg Tablet DT is not associated with hypertension and is classified as a non-opioid analgesic.
The medication Flexar 20mg Tablet DT lacks regulatory approval for managing dysmenorrhea. Clinical trials indicate that piroxicam demonstrates substantial efficacy in alleviating menstrual pain.
The drug Flexar 20mg Tablet DT lacks regulatory approval for migraine management. Clinical trials, however, indicate its efficacy in substantially reducing migraine pain in patients without aura.
Affirmative. This medication may alleviate back pain. Nevertheless, a physician's consultation to determine the underlying cause of your back pain is crucial before initiating treatment. Avoid self-treating with Flexar 20mg Tablet DT, as the etiology of back pain varies individually.
Indeed, Flexar 20mg Tablet DT is suitable for managing acute gout. Clinical trials have demonstrated its significant efficacy in treating acute gout episodes.
Blood donation is permissible while taking Flexar 20mg Tablet DT; however, pre-donation consultation with your physician is recommended.
In diabetic patients, the use of Flexar 20mg Tablet DT requires prior medical consultation. Prolonged use of this medication carries a significant risk of inducing renal failure. Since diabetes is itself a risk factor for kidney disease, adding piroxicam increases the likelihood of renal failure considerably.
Individuals with impaired kidney function should avoid Flexar 20mg DT tablets, as prolonged use of nonsteroidal anti-inflammatory drugs (NSAIDs) can cause kidney damage, including papillary necrosis.
Skin reactions, potentially severe and even life-threatening, are a known side effect of Flexar 20mg Tablet DT. These include exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN). Serious reactions can develop unexpectedly. Discontinue use and consult your physician immediately if a rash, even a mild one, appears.
The use of Flexar 20mg Tablet DT is contraindicated during pregnancy. Its administration may result in premature ductus arteriosus closure, potentially causing fetal cardiac failure and infant mortality.
Patients with active peptic ulcers should not use Flexar 20mg Tablet DT. This medication is associated with the risk of gastric ulceration and hemorrhage.
Individuals with asthma may exhibit heightened sensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin, potentially triggering severe asthma episodes. Physician consultation is advised prior to commencing NSAID therapy.
Affirmative. The use of Flexar 20mg Delayed-Release Tablets may, in certain instances, result in temporary infertility. Piroxicam's mode of action can potentially impede or inhibit the release of ovarian follicles, a phenomenon linked to reversible infertility in some female patients. Physician consultation is advised prior to commencing treatment.
Concurrent use of Flexar 20mg Tablet DT and diuretics is contraindicated. In certain individuals, Flexar 20mg Tablet DT diminishes the sodium-excreting action of furosemide and thiazide diuretics. This interaction is believed to result from suppressed renal prostaglandin production.
Concurrent use of Flexar 20mg Tablet DT and lithium is contraindicated. Flexar 20mg Tablet DT elevates lithium plasma concentrations and diminishes renal lithium excretion. This effect stems from the NSAID's inhibition of renal prostaglandin production. Prior to initiating Flexar 20mg Tablet DT, physician consultation is mandatory.
Concurrent use of Flexar 20mg Delayed-Release tablets and warfarin is contraindicated due to the heightened risk of hemorrhage. Patients should disclose warfarin use to their physician before commencing Flexar therapy. Should concomitant administration be necessary, rigorous monitoring is essential.
Individuals using corticosteroids or anticoagulants face a heightened risk of developing gastric ulcers. Prolonged medication use, alcohol consumption, tobacco use, and advanced age are additional contributing factors to this increased risk.
Individuals experiencing asthma, urticaria, or other allergic responses to aspirin, other nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics, either immediately preceding or following coronary artery bypass grafting.
Gastrointestinal distress, and in uncommon instances, severe gastrointestinal adverse reactions including peptic ulcers and hemorrhage; severe cutaneous reactions like exfoliative dermatitis, Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis; hepatic failure; and kidney impairment.
Flexar 20mg Tablet DT
48
MRP 58
17% off